Review article · 2020

Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders

Pengfei Xu, Pei Shen, Bin Yu, Xi Jin Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, JuBo Wang

European Journal of Medicinal Chemistry, 192, 112155 · Published 18 February 2020 · DOI 10.1016/j.ejmech.2020.112155

View at the publisherCite this paper

In brief

“Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders” is a 2020 review article by Pengfei Xu and 9 co-authors, published in European Journal of Medicinal Chemistry. OpenAlex counts 86 citations as of 21 November 2026, which puts it in the top 2% of works published in 2020 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
86
Most cited in
2024 (18)
Field-weighted impact
1.01
References
151
Authors
10

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xu, P., Shen, P., Yu, B., Xu, X. J., Ge, R., Cheng, X., Chen, Q., Bian, J., Li, Z., & Wang, J. (2020). Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry, 192, 112155. https://doi.org/10.1016/j.ejmech.2020.112155

MLA 9

Xu, Pengfei, et al. “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.” European Journal of Medicinal Chemistry, vol. 192, 2020, p. 112155. https://doi.org/10.1016/j.ejmech.2020.112155.

Chicago

Xu, Pengfei, Pei Shen, Bin Yu, Xi Jin Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, and JuBo Wang. 2020. “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders.” European Journal of Medicinal Chemistry 192: 112155. https://doi.org/10.1016/j.ejmech.2020.112155.

Harvard

Xu, P. et al. (2020) ‘Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders’, European Journal of Medicinal Chemistry, 192, p. 112155. doi:10.1016/j.ejmech.2020.112155.

IEEE

P. Xu et al., “Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders,” European Journal of Medicinal Chemistry, vol. 192, p. 112155, 2020, doi: 10.1016/j.ejmech.2020.112155.

BibTeX

@article{xu2020janus,
  title     = {{Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders}},
  author    = {Xu, Pengfei and Shen, Pei and Yu, Bin and Xu, Xi Jin and Ge, Raoling and Cheng, Xinying and Chen, Qiuyu and Bian, Jinlei and Li, Zhiyu and Wang, JuBo},
  journal   = {European Journal of Medicinal Chemistry},
  year      = {2020},
  volume    = {192},
  pages     = {112155},
  doi       = {10.1016/j.ejmech.2020.112155},
  url       = {https://doi.org/10.1016/j.ejmech.2020.112155}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202099
202177
20221212
20231616
20241818
20251313
20261111

Its field-weighted citation impact is 1.01: it has been cited 1.01 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions

  • Janus kinase
  • JAK inhibitors
  • autoimmune disease
  • myeloproliferative neoplasms
  • JAK/STAT signaling
  • cytokine signaling
  • STAT phosphorylation
  • small-molecule kinase inhibitors

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Xu, P., Shen, P., Yu, B., Xu, X. J., Ge, R., Cheng, X., Chen, Q., Bian, J., Li, Z., & Wang, J. (2020). Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. European Journal of Medicinal Chemistry, 192, 112155. https://doi.org/10.1016/j.ejmech.2020.112155

How many times has this paper been cited?

86 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Pengfei Xu, Pei Shen, Bin Yu, Xi Jin Xu, Raoling Ge, Xinying Cheng, Qiuyu Chen, Jinlei Bian, Zhiyu Li, JuBo Wang.

What is the DOI of this paper?

10.1016/j.ejmech.2020.112155, permanently at https://doi.org/10.1016/j.ejmech.2020.112155. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.